-
???insights.card.a11y.category??? news News
Pfizer ‘a victim of their own success’ amid lagging COVID vaccine sales: Analyst
-
???insights.card.a11y.category??? news News
The case for a rebound in industrials
-
???insights.card.a11y.category??? news News
Payments space has seen ‘a mountain of growth,’ analyst says
-
???insights.card.a11y.category??? news News
Mizuho maintains neutral rating on Mondelez (MDLZ) stock following earnings
-
???insights.card.a11y.category??? news News
Mizuho Americas wins eight IFR awards
-
???insights.card.a11y.category??? news News
Investing in oncology-focused companies
-
???insights.card.a11y.category??? news News
Mizuho's $650 price target on Intuit (INTU) ahead of tax day
-
???insights.card.a11y.category??? news News
The December inflation number will probably be 5% year over year, says Mizuho’s Ricchiuto
-
???insights.card.a11y.category??? news News
Oncology stocks as high risk, high reward